Comparative evaluation of anti-depressant effects of Citalopram, Ketamine and their combination in animal models of depression: A potential anti-depressant?
Open Access
- 11 May 2021
- journal article
- Published by Peertechz Publications Private Limited in Open Journal of Pharmacology and Pharmacotherapeutics
- Vol. 6 (1), 004-008
- https://doi.org/10.17352/ojpp.000016
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Treatment-resistant depression: therapeutic trends, challenges, and future directionsPatient Preference and Adherence, 2012
- Ketamine for Treatment-Resistant Unipolar DepressionCNS Drugs, 2012
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- Depression, suicidality and antidepressants: A coincidence?Indian Journal of Psychiatry, 2010
- Differential effects of acute and repeated citalopram in mouse models of anxiety and depressionInternational Journal of Neuropsychopharmacology, 2009
- Differentiating antidepressants of the future: Efficacy and safetyPharmacology & Therapeutics, 2007
- Optimising antidepressant use in clinical practice: towards criteria for antidepressant selectionThe British Journal of Psychiatry, 2001
- Treatment of severe depressionPsychoneuroendocrinology, 2000
- N-methyl-d-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug developmentNeuropsychopharmacology, 1995
- Depression: a new animal model sensitive to antidepressant treatmentsNature, 1977